These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3935586)
1. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties. Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs. Chand N; Pillar J; Diamantis W; Sofia RD Agents Actions; 1985 Jul; 16(5):318-22. PubMed ID: 2413739 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigs. Chand N; Nolan K; Diamantis W; Perhach JL; Sofia RD Allergy; 1986 Sep; 41(7):473-8. PubMed ID: 3098130 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes. Chand N; Pillar J; Diamantis W; Sofia RD Int Arch Allergy Appl Immunol; 1985; 77(4):451-5. PubMed ID: 2410374 [TBL] [Abstract][Full Text] [Related]
5. Modulation of in vitro anaphylaxis of guinea-pig isolated tracheal segments by azelastine, inhibitors of arachidonic acid metabolism and selected antiallergic drugs. Chand N; Diamantis W; Sofia RD Br J Pharmacol; 1986 Feb; 87(2):443-8. PubMed ID: 3082402 [TBL] [Abstract][Full Text] [Related]
6. A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions. Koda A; Miura T; Inagaki N; Sakamoto O; Arimura A; Nagai H; Mori H Int Arch Allergy Appl Immunol; 1990; 92(3):209-16. PubMed ID: 1703513 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action. Chand N; Pillar J; Diamantis W; Perhach JL; Sofia RD Eur J Pharmacol; 1983 Dec; 96(3-4):227-33. PubMed ID: 6202531 [TBL] [Abstract][Full Text] [Related]
8. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413). Fukuda T; Saito T; Tajima S; Shimohara K; Ito K Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells. Fields DA; Pillar J; Diamantis W; Perhach JL; Sofia RD; Chand N J Allergy Clin Immunol; 1984 Mar; 73(3):400-3. PubMed ID: 6199399 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of a new antiallergic agent, azelastine, on passive cutaneous anaphylaxis and expulsion of Nippostrongylus brasiliensis. Kaji R; Kamijo T; Kojima S Immunopharmacology; 1981 Feb; 3(1):49-52. PubMed ID: 6112210 [TBL] [Abstract][Full Text] [Related]
11. Antiallergic effects of astemizole on immediate type hypersensitivity reactions. Tasaka K; Akagi M; Izushi K; Mio M Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of mouse ear PCA. Inagaki N; Goto S; Nagai H; Koda A Int Arch Allergy Appl Immunol; 1985; 78(2):113-7. PubMed ID: 2864316 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of allergic histamine release from rat peritoneal mast cells by azelastine. Interaction with selected antiasthmatic drugs. Chand N; Pillar J; Diamantis W; Sofia RD Int Arch Allergy Appl Immunol; 1988; 86(3):256-60. PubMed ID: 2456990 [TBL] [Abstract][Full Text] [Related]
14. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. Achterrath-Tuckermann U; Weischer CH; Szelenyi I Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance. Achterrath-Tuckermann U; Simmet T; Luck W; Szelenyi I; Peskar BA Agents Actions; 1988 Jul; 24(3-4):217-23. PubMed ID: 2902760 [TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients. Magnussen H Chest; 1987 Jun; 91(6):855-8. PubMed ID: 2884081 [TBL] [Abstract][Full Text] [Related]
17. [Antiallergic effects of a novel compound, SWR-00151]. Tanaka Y; Masai E; Yashima T; Furukawa M Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349 [TBL] [Abstract][Full Text] [Related]
18. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals. Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414. Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252 [TBL] [Abstract][Full Text] [Related]
20. Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). I. Inhibition of IgE-induced passive cutaneous anaphylaxis (PCA) in rats. Tsuzurahara K; Murata T; Ishikawa S; Date T; Takeyama S Jpn J Pharmacol; 1986 Jan; 40(1):37-46. PubMed ID: 2937947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]